Connect Stock Analysis

The current indifference towards the small price fluctuations of Connect Biopharma could raise concerns from investors as the firm it trading at a share price of 0.0 on very low momentum in volume. The company directors and management did not add any value to Connect Biopharma investors in July. However, most investors can still diversify their portfolios with Connect Biopharma to hedge their inherited risk against high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently very low. The very small Stock volatility is a good signal to investors with longer-term investment horizons.
Check out Trending Equities.

Search Stock Analysis 

 
Refresh
The Connect Biopharma stock analysis report makes it easy to digest most publicly released information about Connect Biopharma and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Connect Stock analysis module also helps to analyze the Connect Biopharma price relationship with some important fundamental indicators such as market cap and management efficiency.

Connect Stock Analysis Notes

The company had not issued any dividends in recent years. Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company was founded in 2012 and is headquartered in Taicang, China. Connect Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 62 people. For more info on Connect Biopharma Holdings please contact the company at 86 512 5357 7866 or go to http://www.connectbiopharm.com.

Connect Biopharma Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Connect Biopharma's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Connect Biopharma Holdings or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Connect Biopharma is not yet fully synchronised with the market data
Connect Biopharma has some characteristics of a very speculative penny stock
Connect Biopharma has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (118.59 M).
Connect Biopharma has a frail financial position based on the latest SEC disclosures

Connect Biopharma SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Connect Biopharma prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Connect Biopharma investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Connect Biopharma specific information freely available to individual and institutional investors to make a timely investment decision.
16th of June 2021
Other Events
View
7th of June 2021
Unclassified Corporate Event
View
3rd of June 2021
Other Events
View
17th of May 2021
Other Events
View
11th of May 2021
Other Events
View
29th of March 2021
Unclassified Corporate Event
View

Connect Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 1.06 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Connect Biopharma's market, we take the total number of its shares issued and multiply it by Connect Biopharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Connect Profitablity

Connect Biopharma's profitability indicators refer to fundamental financial ratios that showcase Connect Biopharma's ability to generate income relative to its revenue or operating costs. If, let's say, Connect Biopharma is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Connect Biopharma's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Connect Biopharma's profitability requires more research than a typical breakdown of Connect Biopharma's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2021
Return on Average Assets(0.96) (1.04) 
Return on Average Equity 1.06  1.05 
Return on Invested Capital(18.76) (20.24) 

Management Efficiency

The entity has return on total asset (ROA) of (14.75) % which means that it has lost $14.75 on every $100 spent on asset. This is way below average. Connect Biopharma management efficiency ratios could be used to measure how well connect biopharma manages its routine affairs as well as how well it operates its assets and liabilities. As of August 1, 2021, Return on Average Assets is expected to decline to -1.04. In addition to that, Return on Average Equity is expected to decline to 1.05. As of August 1, 2021, Total Assets is expected to decline to about 992.9 M. In addition to that, Current Assets is expected to decline to about 967.2 M
Last ReportedProjected for 2021
Book Value per Share(17.10) (18.45) 
Tangible Assets Book Value per Share 18.10  17.99 
Tangible Asset Value1.1 B992.6 M

Connect Biopharma Technical and Predictive Indicators

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Connect Biopharma to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Equity Valuation Now

   

Equity Valuation

Check real value of public entities based on technical and fundamental data
All  Next Launch Module
Check out Trending Equities. Note that the Connect Biopharma information on this page should be used as a complementary analysis to other Connect Biopharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Tools for Connect Stock

When running Connect Biopharma price analysis, check to measure Connect Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Connect Biopharma is operating at the current time. Most of Connect Biopharma's value examination focuses on studying past and present price action to predict the probability of Connect Biopharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Connect Biopharma's price. Additionally, you may evaluate how the addition of Connect Biopharma to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go